Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis
Marta Santisteban(Navarre Institute of Health Research), Susana Inogés(Universidad de Navarra), Laura Hato(Unknown), Belén P. Solans(Navarre Institute of Health Research), N. Rodríguez-Spiteri(Clinica Universidad de Navarra), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Estefanía Toledo(Instituto de Salud Carlos III), B. Olartecoechea(Clinica Universidad de Navarra), Miguel Á. Idoate(Universidad de Navarra), Esteban Salgado(Complejo Hospitalario de Navarra), Amaia Urrizola(Clinica Universidad de Navarra), Luis D. Mejías(Clinica Universidad de Navarra), Ascensión López-Dı́az de Cerio(Complejo Hospitalario de Navarra)
Cited by 29
Related Papers
Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial
|JAMA Internal Medicine|2015|510
Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells
|Cancer Research|2009|378
The Mediterranean diet, plasma metabolome, and cardiovascular disease risk
|European Heart Journal|2020|372
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
|International Journal of Epidemiology|2018|325